Aurinia Pharmaceuticals
AUPH
AUPH
67 hedge funds and large institutions have $107M invested in Aurinia Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
+3
Holders Change %
+4.69%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
17
Reduced
18
Closed
7
Calls
$1M
Puts
$2.42M
Net Calls
-$1.42M
Net Calls Change
+$777K
Top Buyers
Top Sellers
1 |
Morgan Stanley
New York
|
-$2.99M |
2 |
O
OrbiMed
New York
|
-$2.58M |
3 |
![]()
Alyeska Investment Group
Chicago,
Illinois
|
-$2.18M |
4 |
D.E. Shaw & Co
New York
|
-$660K |
5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$394K |